Raw Materials CAS 4291-63-8 Cladribine 99% Purity Cladribine Powder API Cladribine

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: Dsung-Cladribine
• Product Name: Cladribine
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antineoplastic
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 4291-63-8
• Mf: C10h12cln5o3
• MW: 285.688
• Density: 2.03
• Melting Point: 181-185 C(Lit.)
• Boiling Point: 547.6 C at 760 Mmhg
• Refractive Index: 1.871
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 1 Ton/Month

Product Description

Raw Materials CAS 4291-63-8 Cladribine 99% Purity Cladribine Powder API Cladribine

Product Description

Product Details

Product Name	Cladribine
Appearance	White powder
CAS No.	4291-63-8
MF	C10H12ClN5O3
MW	285.688

Cladribine is a white powder, Cladribine is a synthetic anti-cancer agent that also suppresses the immune system.   Chemically, Cladribine mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, which interferes with the cell's ability to process DNA.   Cladribine is easily destroyed by normal cells except for blood cells, with the result that it produces relatively few side effects and results in very little non-target cell loss.

Application & Function

Cladribine is a synthetic anti-cancer agent that also suppresses the immune system.   Chemically, Cladribine mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, which interferes with the cell's ability to process DNA. Cladribine is easily destroyed by normal cells except for blood cells, with the result that it produces relatively few side effects and results in very little non-target cell loss.
Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis) and multiple sclerosis. Cladribine is used for the treatment of symptomatic hairy cell leukemia and is administered by injection.  According to the Histiocytosis Association, cladribine is used to treat histiocytosis.

Specification